IQVIA Holdings stock performance snapshot

IQVIA Holdings (IQV) has drawn investor attention after a mixed stretch for the stock, with a decline year to date but a gain over the past year and modest progress over the past month and past 3 months.

At a share price of US$167.90, IQVIA’s recent moves show fading short term momentum, with the 1 day and 7 day share price returns slightly down, even as the 1 year total shareholder return remains strongly positive.

If IQVIA’s recent pullback has you thinking about risk and opportunity, this can be a good moment to scan for other healthcare focused AI stocks using our 34 healthcare AI stocks.

With IQVIA trading at US$167.90 and showing an indicated intrinsic discount alongside a sizeable gap to analyst targets, you have to ask: is this stock still underappreciated, or is the market already pricing in its future growth?

Most Popular Narrative: 26.6% Undervalued

IQVIA’s most followed narrative puts fair value at US$228.60 versus the last close of US$167.90, framing the stock as materially discounted on that view.

Accelerated adoption of AI-driven analytics and data solutions, supported by strong client demand and high-profile industry partnerships like NVIDIA, positions IQVIA for improved operational efficiency, faster project execution, and differentiation, which should support future revenue growth and eventual margin expansion as AI capabilities scale.

Curious how that AI story translates into numbers? The fair value hinges on a tight link between projected revenue gains, firmer margins and a higher future earnings multiple. The key is how those threads are stitched together.

This widely followed narrative applies a discount rate of 8.83% to IQVIA’s projected cash flows, pairs it with measured revenue and earnings growth assumptions, and then layers on a future P/E multiple that sits below the current Life Sciences industry level. The result is a fair value estimate meaningfully above today’s price, built on specific expectations for IQVIA’s data assets, AI adoption and long term profitability rather than broad market optimism.

Result: Fair Value of $228.60 (UNDERVALUED)

However, this hinges on AI actually lifting demand rather than compressing project pricing, and on higher leverage not limiting IQVIA’s flexibility if conditions tighten.

Next Steps

With both risks and rewards in play, does this story line up with how you see IQVIA today, or raise fresh questions about the stock? Spend a few minutes with the underlying data, stress test the assumptions, and review the 5 key rewards and 1 important warning sign.

Looking for more investment ideas?

If IQVIA has your attention, do not stop here. Broaden your watchlist with other stock ideas that share solid fundamentals, income potential, or underappreciated value.

• Spot underpriced opportunities early by scanning stocks that combine quality and value using the 49 high quality undervalued stocks.
• Strengthen the income side of your portfolio with companies offering robust yields through the 10 dividend fortresses.
• Sleep easier at night by focusing on companies that show resilience and lower risk profiles via the 67 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.